Loading ...

Stock Quote cris

cris Stock Price Today

cris Price History

cris Stock Price History

cris History

Last Price cris

Close Price cris

Day Change cris

After Hours Quote cris

Open Price cris

Day Range cris

Year Range cris

Projected Yield cris

Market Cap cris

Stock Volume cris

Average Volume cris

Forward Price cris

PE for cris

PB for cris

PS for cris

PCF for cris

price earnings ratio cris

price to book ratio cris

price to sales ratio cris

price to cash flow ratio cris

Stock Quote Curis Inc

Curis Inc Stock Price today

Curis Inc Price history

Curis Inc Stock Price history

Curis Inc history

Last Price Curis Inc

Close Price Curis Inc

Day Change Curis Inc

After Hours Quote for Curis Inc

Open Price Curis Inc

Day Range Curis Inc

Year Range Curis Inc

Projected Yield Curis Inc

Market Cap Curis Inc

Stock Volume Curis Inc

Average Volume Curis Inc

Forward Price Curis Inc

pe Curis Inc

pb Curis Inc

ps Curis Inc

pcf Curis Inc

price earnings ratio Curis Inc

price to book ratio Curis Inc

price to sales ratio Curis Inc

price to cash flow ratio Curis Inc

What Does This Company Do?
Curis, Inc., is a drug discovery and development company. The Company is engaged in the development of its proprietary targeted cancer drug candidates, including CUDC-907, HDAC and phosphatidylinositol-3-kinase, or PI3K.
Sector
Healthcare
Industry
Biotechnology
Stock Type
Slow Growth
Employees
33
Stock Style
Small Core

Key Stats  CRIS More...

Key Stats CRIS

S&P 500 index data: S&P 500 Copyright ©

All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .

Sponsor Center

News  cris - Curis Inc More...

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days

Analysis  cris - Curis Inc More...

Free Issue - Morningstar's Dividend Newsletter
More...

An investment is only as good as the cash it returns directly to your pockets. That's why Morningstar DividendInvestor's buy and sell recommendations are driven entirely by dividends. Our total-return strategy gives you carefully selected, picks that combine current income and income growth to generate large, reliable and growing cash returns. Click to try!

More reports cris - Curis IncMore...

Click above to view more mutual fund data and stats for cris - Curis Inc.

  • Performance
  • Asset Allocation
  • Dividend and Capital Gains Distribution
  • News, Alerts and Opinions
  • Video reports
  • Management
  • Filings

Ownership   CRIS More ...

Ownership CRIS

Fidelity® Select Biotechnology Portfolio
Vanguard Total Stock Mkt Idx
iShares Nasdaq Biotechnology
Vanguard Extended Market Idx Inv
Franklin Biotechnology Discovery A

Wall St. Recommendations  cris - Curis Inc More...

Wall Street Analyst Recommendation CRIS

Stock Price Quote: cris Curis Inc - XNAS - Morningstar
Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry

Previous: 060280 - Curexo Inc  |  Next: cris - Curis Inc